Effect of septic shock on lipolytic activity in rats' blood and adipose tissue
Leonard Kraśnik, Janusz PaluszakMed Sci Monit 1999; 5(5): BR845-849 :: ID: 503270
Abstract
The metabolic study of septic shock indicates an intensification of anaerobic glycolysis, gluconeogenesis, proteolysis and limitation of lipid utilisation as a source of energy. The object of this study is the influence of a septic shock on lipolytic activity in the rats` blood and adipose tissue. The septic shock was developed by intraperitoneal injection of bacterial suspension (107 E. coli). The blood was taken in the hyperdynamic (I phase) and hypodynamic (II phase) period of a septic shock and the levels of glucose, insulin, free fatty acids (FFA), triglycerides (TG), total cholesterol (TC) and its fractions (HDL, LDL), lipolytic activity of serum (LAS) and lipid mobilising activity (LMA) were determined. Results: the glucose concentration in blood was increased in phase I of the septic shock to 8.70±1.30 mmol/l, in phase II it was decreased to 2.93±0.42 mmol/l. The insulin level of blood serum was increased to 16.15±3.60 µU/ml in phase I of the septic shock, in phase II, the insulin level was decreased to the level which was observed in the control group (8.15±1.71 µU/ml). The concentration of serum TC progressively decreased during the septic shock, as well as the HDL-cholesterol concentration. The concentration of the LDL-cholesterol fraction was increased to 0.26±0.01 mmol/l in phase I, and in phase II it decreased to 0.14±0.03 mmol/l. We demonstrated the increase of serum TG to 1.93±0.65 mmol/l with its reduction of FFA to 0.37±0.06 mmol/l in phase I of the septic shock. In phase II, the TG concentration decreased to 1.34±0.12 mmol/l, but it was still higher than in the control group (0.92±0.10 mmol/l) and the FFA concentration was increased to 1.22±0.26 mmol/l. In phase I of the septic shock, the LAS was increased to 1.88±0.52 µm/ml/h, in phase II it was decreased to 0.02±0.01 µm/ml/h. The LMA progressively increased during the septic shock and in phase II it reached 0.21±0.07 µm/ml/h.
Keywords: Lipid Metabolism, lipolytic activity, septic shock
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952